Patient safety measures continue to evolve globally, particularly with the increased number of emerging specialty medicines. Traditional initiatives focused on
Understanding the Canadian Product Monograph (PM) requirements is essential for regulatory affairs, pharmacovigilance, medical information and other professionals working in